Literature DB >> 2642747

Human pharmacokinetics of carboplatin after oral administration.

M B van Hennik, W J van der Vijgh, I Klein, J B Vermorken, H M Pinedo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2642747     DOI： 10.1007/bf00273533

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  4 in total

1.  On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation.

Authors:  F Elferink; W J van der Vijgh; H M Pinedo
Journal:  Anal Chem       Date:  1986-09       Impact factor: 6.986

2.  Pharmacokinetics of carboplatin after i.v. administration.

Authors:  F Elferink; W J van der Vijgh; I Klein; J B Vermorken; H E Gall; H M Pinedo
Journal:  Cancer Treat Rep       Date:  1987-12

Review 3.  Carboplatin: the clinical spectrum to date.

Authors:  R Canetta; M Rozencweig; S K Carter
Journal:  Cancer Treat Rev       Date:  1985-09       Impact factor: 12.111

4.  Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

Authors:  A H Calvert; S J Harland; D R Newell; Z H Siddik; A C Jones; T J McElwain; S Raju; E Wiltshaw; I E Smith; J M Baker; M J Peckham; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  4 in total
  5 in total

Review 1.  Clinical pharmacokinetics and dose optimisation of carboplatin.

Authors:  S B Duffull; B A Robinson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 2.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

Review 3.  Clinical pharmacokinetics of carboplatin.

Authors:  W J van der Vijgh
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 4.  Comparative adverse effect profiles of platinum drugs.

Authors:  M J McKeage
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

Review 5.  New platinum agents. A comparison in ovarian cancer.

Authors:  L R Kelland; M J McKeage
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.